BSc MSc PGCert PhD MRSB FRSC
Dr Sandra Appiah currently works at the Department of Natural Sciences, Middlesex University, UK.
She specialises in teaching metabolic and nutritional biochemistry. Her research focus is on the modulation of death and survival signaling pathways in cell models of leukaemia and Alzheimer’s disease by phytochemicals.
Roberts, Helen C. and Punev, Ivan Petkov and Allardyce, Duncan and Kyprianou, Anna and Appiah, Sandra S. and Megeney, Alison and Calin, Anastasia and Gallacher, Deeba and Mill, Rachel (2022) Intentionality for inclusivity - the journey at Middlesex University. Project Report. McGraw Hill. (Accepted/In press)
Vu, Milan and Kassouf, Nick and Appiah, Sandra S. (2021) Betulinic Acid–Doxorubicin-Drug combination induced apoptotic death via ROS stimulation in a relapsed AML MOLM-13 cell model. Antioxidants , 10 (9). ISSN 2076-3921
Osemeke, Cynthia and Wen, Xuesong and Garelick, Hemda and Appiah, Sandra S. (2021) α-Mangostin and Doxorubicin Combination Synergistically Inhibited Cell Growth, Induced Cell Apoptosis with Increased Bak Protein and Decreased FLT3-ITD Phosphorylation in AML MOLM-13 Cell Line. Clinical Oncology and Research , 4 (8). pp. 1-10. ISSN 2613-4942
Vu, Milan and Kassouf, Nick and Ofili, Rosemary and Lund, Torben and Bell, Celia M. and Appiah, Sandra S. (2020) Doxorubicin selectively induced apoptosis through inhibition of a novel isoform of Bcl-2 in acute myeloid leukaemia MOLM-13 cells with reduced Beclin 1 expression. International Journal of Oncology , 57 (1). pp. 113-121. ISSN 1019-6439
Vu, Milan and Kassouf, Nick and Ofili, Rosemary and Lund, Torben and Bell, Celia M. and Appiah, Sandra S. (2020) Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression. International Journal of Oncology , 57 (1). pp. 113-121. ISSN 1019-6439
Chair of the Natural Science Research Ethics Sub-Committee
